Back to HomeBeta

ICD-10 Coding for Ductal Carcinoma(C50.911, D05.10)

Complete ICD-10-CM coding and documentation guide for Ductal Carcinoma. Includes clinical validation requirements, documentation requirements, and coding pitfalls.

Also known as:

Invasive Ductal CarcinomaDuctal Carcinoma In SituIDCDCIS

Related ICD-10 Code Ranges

Complete code families applicable to Ductal Carcinoma

C50.0-C50.9Primary Range

Malignant neoplasm of breast

This range includes codes for malignant neoplasms of the breast, including ductal carcinoma.

Carcinoma in situ of breast

This range includes codes for carcinoma in situ of the breast, relevant for DCIS.

Code Comparison: When to Use Each Code

Compare key differences between these codes to ensure accurate selection

CodeDescriptionWhen to UseKey Documentation
C50.911Malignant neoplasm of unspecified site of right female breastUse when the specific site within the right breast is not documented.
  • Histological confirmation of invasive ductal carcinoma
  • Imaging studies indicating malignancy
D05.10Carcinoma in situ of unspecified breastUse when DCIS is confirmed without specification of laterality.
  • Pathology report confirming DCIS
  • Absence of invasive components

Clinical Decision Support

Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.

Key Information: ICD-10 code for ductal carcinoma

Essential facts and insights about Ductal Carcinoma

The ICD-10 code for ductal carcinoma varies based on whether it is invasive or in situ, with C50 codes for invasive and D05 codes for in situ.

Primary ICD-10-CM Codes for ductal carcinoma

Malignant neoplasm of unspecified site of right female breast
Billable Code

Decision Criteria

clinical Criteria

  • Histological confirmation of invasive ductal carcinoma

documentation Criteria

  • Lack of specific site documentation within the breast

Applicable To

  • Invasive ductal carcinoma of unspecified site of right breast

Excludes

  • Benign neoplasm of breast
  • Carcinoma in situ of breast

Clinical Validation Requirements

  • Histological confirmation of invasive ductal carcinoma
  • Imaging studies indicating malignancy

Code-Specific Risks

  • Risk of under-coding if specific site is documented but not coded.

Coding Notes

  • Ensure laterality and specific site are documented to avoid unspecified coding.

Ancillary Codes

Additional codes that should be used in conjunction with the main diagnosis codes when applicable.

Personal history of malignant neoplasm of breast

Z85.3
Use for patients with a history of breast cancer post-treatment.

Follow-up examination after treatment for malignant neoplasm

Z08
Use for follow-up visits post-DCIS treatment.

Differential Codes

Alternative codes to consider when ruling out similar conditions to the primary diagnosis.

Carcinoma in situ of unspecified breast

D05.10
Use D05.10 for in situ carcinoma without invasive components.

Malignant neoplasm of unspecified site of right female breast

C50.911
Use C50.911 for invasive ductal carcinoma.

Documentation & Coding Risks

Avoid these common documentation and coding issues when documenting Ductal Carcinoma to ensure proper reimbursement, maintain compliance, and reduce audit risk. These guidelines are particularly important when using ICD-10 code C50.911.

Impact

Clinical: Affects treatment decisions and prognosis., Regulatory: Non-compliance with documentation standards., Financial: Potential impact on reimbursement for targeted therapies.

Mitigation Strategy

Ensure receptor status is included in pathology reports., Review clinical notes for completeness before coding.

Impact

Reimbursement: May lead to reduced reimbursement due to lack of specificity., Compliance: Non-compliance with coding guidelines requiring specificity., Data Quality: Decreases accuracy of health records and data analytics.

Mitigation Strategy

Ensure documentation specifies the site and use the most specific code available.

Impact

Audits may target unspecified codes when documentation supports more specific coding.

Mitigation Strategy

Ensure all documentation is reviewed for specificity before coding.

Documentation errors, coding pitfalls, and audit risks are interconnected aspects of medical coding and billing. Addressing all three areas helps ensure accurate coding, optimal reimbursement, and regulatory compliance.

Frequently Asked Questions

Common questions about ICD-10 coding for Ductal Carcinoma, with expert answers to help guide accurate code selection and documentation.

Documentation Templates for Ductal Carcinoma

Use these documentation templates to ensure complete and accurate documentation for Ductal Carcinoma. These templates include all required elements for proper coding and billing.

Invasive ductal carcinoma diagnosis

Specialty: Oncology

Required Elements

  • Histologic type
  • Tumor size
  • Grade
  • Lymph node involvement
  • Receptor status

Example Documentation

56-year-old female with 2.3 cm Grade II IDC in the right upper inner quadrant, ER 90%, PR 15%, HER2 1+.

Examples: Poor vs. Good Documentation

Poor Documentation Example
Breast cancer diagnosed.
Good Documentation Example
Invasive ductal carcinoma, Grade II, 2.3 cm, right upper inner quadrant, ER 90%, PR 15%, HER2 1+.
Explanation
The good example provides specific details about the type, size, grade, and receptor status, which are essential for accurate coding and treatment planning.

Need help with ICD-10 coding for Ductal Carcinoma? Ask your questions below.

Ask about any ICD-10 CM code, or paste a medical note

We build tools for
clinician happiness.

Learn More at Freed.ai
Back to HomeBeta

Built by Freed

Try Freed for free for 7 days.

Learn more